How the endothelium and its bone marrow-derived progenitors influence development of disease

Medical Hypotheses

Volumn 62, Issue 2, 2004, Pages 247-251

  Štefanec, Tihomir ^a,b  

^a BROWN UNIVERSITY   (United States)

^b MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; BODY HEIGHT; CANCER; CELL PROLIFERATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIUM; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GENOTYPE; HEMATOPOIETIC STEM CELL; HUMAN; HYPERTENSION; INHERITANCE; PLACENTA; PREECLAMPSIA; PRENATAL DISORDER; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SENESCENCE; TELOMERE; TISSUE GROWTH;

EID: 1342289616     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00327-X     Document Type: Article

References (45)

1. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527-61.
2. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-60.
3. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med 2003;348:593-600.
4. Benekli M, Gullu IH, Tekuzman G, et al. Circulating intercellular adhesion molecule-1 and E-selectin levels in gastric cancer. Br J Cancer 1998;78:267-71.
5. Blann AD, Tse W, Maxwell SJ, Waite MA. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 1994;12:925-8.
6. Cominacini L, Fratta Pasini A, Garbin U, et al. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 1995;38:1122-4.
7. Tempfer C, Zeisler H, Hefler L, Schatten C, Husslein P, Kainz C. Serum levels of ELAM-1, but not CD44, predict the clinical outcome of patients with preeclampsia. Hypertens Pregnancy 1999;18:45-55.
8. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002;105:3017-24.
9. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194-201.
10. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 1995;92:11190-4.
11. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002;105:1541-4.
12. Asai K, Kudej RK, Shen YT, et al. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vase Biol 2000;20:1493-9.
13. Dimmeler S, Haendeler J, Galle J, Zeiher AM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation 1997;95:1760-3.
14. Breitschopf K, Zeiher AM, Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett 2001;493:21-5.
15. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-7.
16. Kureishi Y, Luo Z, Shiojima I, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000;6:1004-10.
17. Assmus B, Urbich C, Aicher A, et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 2003;92:1049-55.
18. Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001;103:2885-90.
19. Weis M, Pehlivanli S, Meiser BM, von Scheidt W. Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation. J Am Coll Cardiol 2001;38:814-8.
20. Dewberry RM, Crossman DC, Francis SE. Interleukin-1 receptor antagonist (IL-1RN) genotype modulates the replicative capacity of human endothelial cells. Circ Res 2003;92:1285-7.
21. Wang X, Yi S, Athayde N, Trudinger B. Endothelial cell apoptosis is induced by fetal plasma from pregnancy with umbilical placental vascular disease. Am J Obstet Gynecol 2002;186:557-63.
22. Wang Y, Adair CD, Coe L, Weeks JW, Lewis DF, Alexander JS. Activation of endothelial cells in preeclampsia: increased neutrophil-endothelial adhesion correlates with up-regulation of adhesion molecule P-selectin in human umbilical vein endothelial cells isolated from preeclampsia. J Soc Gynecol Investig 1998;5:237-43.
23. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhausl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 1995;44:1323-7.
24. Martin H, Hu J, Gennser G, Norman M. Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birthweight. Circulation 2000;102:2739-44.
25. Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998;97:1695-701.
26. Wong TY, Klein R, Sharrett AR, et al. ARIC Investigators. Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 2002;287:2528-33.
27. Štefanec T. Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease? Chest 2000;117:841-54.
28. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. New Engl J Med 1995;333:1757-63.
29. Cubeddu LX, Hoffmann IS. Insulin resistance and upper-normal glucose levels in hypertension: a review. J Hum Hypertens 2002;16:S52-5.
30. van Beck E, Peeters LL. Pathogenesis of preeclampsia: a comprehensive model. Obstet Gynecol Surv 1998;53:233-9.
31. Thame M, Osmond C, Wilks RJ, Bennett FI, McFarlane-Anderson N, Forrester TE. Blood pressure is related to placental volume and birth weight. Hypertension 2000;35:662-7.
32. Sichieri R, Siqueira KS, Pereira RA, Ascherio A. Short stature and hypertension in the city of Rio de Janeiro, Brazil. Public Health Nutr 2000;3:77-82.
33. Innes KE, Byers TE. Preeclampsia and breast cancer risk. Epidemiology 1999;10:722-32.
34. Cohn BA, Cirillo PM, Christianson RE, van den Berg BJ, Siiteri PK. Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst 2001;93:1133-40.
35. Andersson SW, Bengtsson C, Hallberg L, Lapidus L, Niklasson A, Wallgren A, Hulthen L. Cancer risk in Swedish women: the relation to size at birth. Br J Cancer 2001;84:1193-8.
36. Davey Smith G, Hart C, Upton M, Hole D, Gillis C, Watt G, Hawthorne V. Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality. J Epidemiol Commun Health 2000;54:97-103.
37. Kousta E, Lawrence NJ, Penny A, Millauer BA, Robinson S, Johnston DG, et al. Women with a history of gestational diabetes of European and South Asian origin are shorter than women with normal glucose tolerance in pregnancy. Diabet Med 2000;17:792-7.
38. Thame M, Wilks RJ, McFarlane-Anderson N, Bennett FI, Forrester TE. Relationship between maternal nutritional status and infant's weight and body proportions at birth. Eur J Clin Nutr 1997;51:134-8.
39. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001; 357:2002-6.
40. Forsen T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D. The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med 2000;133:176-82.
41. Ros HS, Lichtenstein P, Ekbom A, Cnattingius S. Tall or short? Twenty years after preeclampsia exposure in utero: comparisons of final height, body mass index, waist-to-hip ratio, and age at menarche among women, exposed and unexposed to preeclampsia during fetal life. Pediatr Res 2001;49:763-9.
42. Henriksen T, Clausen T. The fetal origins hypothesis: placental insufficiency and inheritance versus maternal malnutrition in well-nourished populations. Acta Obstet Gynecol Scand 2002;81:112-4.
43. Walker JJ. Pre-eclampsia. Lancet 2000;356:1260-5.
44. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxemia of pregnancy. Heart 1997;77:154-8.
45. Popper K. The logic of scientific discovery. London/New York: Routledge Classics; 2002. p. 18.